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SUMMARY
Humidification therapy; long-term effects in COPD and OSAS patients
Humidification therapy is widely used in patients during invasive ventilation and the importance of heating and humidifying the 
inhaled air is well defined in both the acute and long term setting. On the other hand the continuous usage of humidification in 
noninvasive ventilation is controversial and the long term effects are still not well defined. The usage of noninvasive ventilation is 
especially important in hypercapnic Chronic obstructive pulmonary disease (COPD) and also the obstructive sleep apnea syndrome 
(OSAS) patients and compliance to this treatment is essential in long term. Limited number of studies have shown that heated 
humidification is preferred by COPD patients and might help in mucus clearance, reduce mucus viscosity and help in expectoration, 
but there was shown no priority as far as concerns the lung function or blood gas parameters. Humidification might also be important 
in long term oxygen treatment since the inhalation of dry air can lead to ciliary dysfunction, alterations in mucus properties and 
mucociliary clearance impairment. Studies concerning OSAS patients showed that humidification helps to reduce the nasal symptoms 
but plays no role in increasing the compliance of patients in long term. Multi-center studies with large number of patients are needed 
to identify patients’ groups who are likely to benefit from the addition of humidification to noninvasive therapy.
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ÖZET
Nemlendirme tedavisi; KOAH ve OUAS hastalarında uzun vadeli etkileri
Nemlendirme tedavisi, invaziv ventilasyon sırasında yaygın olarak kullanılmaktadır ve inhale havayı ısıtmanın ve nemlendirmenin 
önemi hem akut hem de uzun vadeli sonuçlarla iyi tanımlanmıştır. Öte yandan noninvaziv ventilasyonda sürekli nemlendirmenin 
kullanımı tartışmalıdır ve uzun vadeli etkileri hala iyi tanımlanmamıştır. Hiperkapnik kronik obstruktif akciğer hastalığı (KOAH)’nda 
ve obstrüktif uyku apne sendromu (OUAS) hastalarında noninva-
ziv ventilasyon kullanımı özellikle önemlidir ve bu tedaviye uyum 
uzun vadede önemlidir. Sınırlı sayıda yapılan çalışmalar, ısıtılmış 
nemlendirme işleminin KOAH hastaları tarafından tercih edildiğini 
ve mukus temizlenmesinde, mukus viskozitesinde azalmaya ve 
balgam söktürmede yardımcı olabileceğini ancak akciğer fonksiyo-
nu veya kan gazı parametreleri ile ilgili herhangi bir önceliğe sahip 
olmadığını göstermiştir. Kuru havanın inhalasyonu siliyer disfonksi-
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Humidification is the process of increasing relative 
humidity of the atmosphere. ın the setting of respira-
tory medicine, humidification during invasive venti-
lation is a standard of care. Heated humidifier (HH) 
and the heat-and-moisture exchanger (HME) are the 
humidification methods. The importance of heating 
and humidifying the inhaled air is well defined for 
patients undergoing invasive ventilation in both the 
acute and long-term setting (1,2). The routine use of 
humidification and long term effects in patients 
receiving noninvasive ventilation (nıV) treatment is 
controversial. ımprovements in mucociliary clear-
ance with humidification have been demonstrated in 
patients with bronchiectasis and chronic obstructive 
pulmonary diseases (COPD) (3). However, there is no 
consensus statement defining the indications, patient 
selection, and technical issues. 
ın this review, effects of humidification in COPd and 
obstructive sleep apnea syndrome (OsAs) will be 
discussed by focusing mainly on the role of humidifi-
cation for improving the adherence of patients with 
OsAs to continuous positive airway pressure (CPAP) 
therapy and long term effects of humidification in 
COPD. 
Humidification Therapy in COPD Patients
The main complaints of COPD patients consist of 
dyspnea, chronic cough and sputum production. The 
retention of mucus due to impaired mucociliary 
transport and an increase in its overall secretion leads 
to the formation of a "suitable" microenvironment for 
bacteria growth which further "alarms" the immune 
system cells especially neutrophils to migrate to the 
airways and start the inflammatory process. This is a 
common scenario which occurs in exacerbations and 
leads to a deterioration of the patients’ clinical out-
come. There are many studies that have shown a 
positive association of sputum production and decline 
in lung function, hospitalization and death (4-7). ıt is 
important to treat these patients appropriately but it is 
also essential to take measures for the prevention of 
such exacerabations. smoking cessation, vaccination 
(flu and pneumococcus), physical activity and pul-
monary rehabilitation are examples of non-pharma-
cological management of COPD patients to improve 
the quality of life. Different treatment strategies to 
facilitate the mucus clearance and reverse the hyper-
secretion have also been developed. Wolkove et al. 
have reported an increase in bronchodilator response 
in stable COPD patients after using a mucus clearing 
device (8). On the other hand eventhough not recom-
mended by guidelines due to lack of well designed 
studies, a variety of mucolytics and antioxidants have 
been developed and seem to be efficacious in 
patients prone to infections (9). ın recent years some 
studies have shown that humidification therapy might 
help in mucus clearance, reduce mucus viscosity and 
help in expectoration in airway diseases. Hasani et al. 
showed that even a short-term application of humid-
ification therapy consisting of 3 hours per day for a 
period of one week increased significantly the muco-
ciliary clearance in patients with bronchieactasis, a 
disorder which is also characterized with sputum 
retention due to abnormal widening of the bronchi 
and their branches (10). ın order to determine the 
long-term effects of the humidification therapy in 
COPD and bronchectasis patients Rea and colleagues 
randomized 108 patients to daily humidification or 
usual care and followed them for 12 months (3). The 
humidified air at 37ºC at a flow rate of  20-25 l/min 
was given by the help of a nasal cannulae and the 
overall mean time of usage was registered as 1.6 
(sd= 0.67) hours per day. At the end this study 
showed that patients on humidification therapy had 
fewer exacerbations days, longer period to next exac-
erbation and reduced exacerbation frequency statisti-
cally significant when compared to usual care group. 
The impact of the humidification therapy was also 
observed in both quality of life scores and improve-
ment of pulmonary funciton tests at the end of  the 3rd 
and 12th month of the study (3).
long-term oxygen therapy for at least 15 hours per 
day is used in COPD patients with chronic respirato-
ry failure in order to improve pulmonary hemody-
namics. nasal oxygen therapy can be administered 
with or without humidification. ın routine practice 
yona, mukus değişikliğe ve mukosiliyer temizleme bozukluğuna neden olabileceğinden, nemlendirme uzun süreli oksijen tedavisinde 
de önemli olabilir. OUAS hastaları ile ilgili yapılan çalışmalar, nemlendirme, burun belirtilerini azaltmaya yardımcı olduğunu ancak 
uzun vadede hastaların uyumluluğunu arttırmada rol oynamadığını göstermiştir. Noninvaziv tedaviye nemlendirmenin eklenmesinden 
fayda sağlayacak hastaların gruplarını belirlemek için daha çok sayıda hastayla yapılan çok merkezli çalışmalara ihtiyaç vardır.
Anahtar kelimeler: Nemlendirme, noninvaziv ventilasyon, KOAH, OSAS, uzun vadeli
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nasal oxygen therapy is administered without humid-
ification. ınhalation of dry air can lead to ciliary 
dysfunction, alterations in mucus properties and 
mucociliary clearance impairment (11,12). 
However, the effects of humidification or no humidi-
fication on mucociliary transport, mucus properties, 
and airway symptoms in patients receiving long-term 
oxygen therapy are not well established. ın the study 
by Franchini et al., cold bubble humidification did 
not prevent slowing of mucociliary clearance, mucus 
dehydration, and worsening pulmonary function; 
cold bubble humidification performed no better than 
no humidification (13). 
Another encountered problem in COPD patients who 
recieve oxygen therapy is the development of hyper-
capnia (14). nıMV is often used in exacerbations and 
also stable hypercapneic COPD patients and it is 
important to increase the compliance of the patients 
for the device. ıt was reported previously that the 
majority of patients who are prescribed nıMV for 
usage at home drop out within the first month due to 
skin irritation, upper airway problems or  air leakage 
(15). nava and colleagues designed a randomized 
crossover pilot study for a period of 12 months to 
compare the clinical effects of heated humidification 
at 34ºC with heat and mositure exchanger during a 
long-term nıMV application in stable hypercapneic 
patients. There was no significant difference between 
the groups as far as concers the tolerance and side 
effects, but the patient number was only eight for 
each group  and interestingly the majority of the 
patients at the end of the study prefered the heated 
humidification system for their treatment at home 
(16). ın another study the role of humidification on 
ventilatory and blood gas parameters was investigat-
ed on 81 patients of whom 52 were hypercapneic 
(17). lellouche et al. did not recommend HME use 
with nıV due to the increased additional dead space 
with decreasing carbondioxide elimination in hyper-
capnic subjects (17).  
On the other hand there are no studies which com-
pare the "humidification" and "no humidification" 
systems and large randomized studies are also need-
ed for the comparison of different humidification 
systems and their effect on upper airway infections.
Another important issue is whether the long-term 
application of such systems is cost effective or not. 
Milne et al. performed an economic evaluation of the 
87 patients who were enrolled in a previous study for 
the long term humidification therapy for a period of 
12 months (3,18). They found that humidification 
therapy applied to  moderate, severe chronic pulmo-
nary disease and bronchectasis patients was cost-ef-
fective at a level acceptable for public funding in 
new Zealand (18). Yet this study has got limitations 
concerning the sample size, the lack of blinding and 
being focused on only one country. Further studies 
with the involvement of more countries and  a larger 
number of patients are needed to enlighten such eco-
nomical issues.
Humidification Therapy in OSAS Patients
nıMV is also the treatment of choice in obstructive 
sleep apnea, a disorder which is characterised by the 
episodic collapse of the upper airway which further 
leads to hypoxemia and an increase in breathing 
effort resulting in arousal (19). This sleep disorder if 
left untreated leads to an excessive daytime sleepi-
ness, impaired neurocognitive function, increase in 
accidents for drivers and is also related to other com-
mon sistemic disorders like hypertension, stroke and 
myocardial infarction (19). 
CPAP, the first-line medical treatment in adults with 
OsAs, effectively improves sleep architecture, reduc-
es the apnea-hypopnea index (AHı), normalizes oxy-
hemoglobin saturation, and decreases neurocognitive 
and cardiovascular sequences (19,20). Eventhough 
all these beneficial effects are extensively reported, 
the adherence rates of patients to treatment which is 
defined as at least 4 hours per day in at least 5 days 
of a week was calculated to be in average as only 
%80 initially and half of the patients usually stop 
using CPAP after one year (21). The need for con-
tinous use and the belief of patients that the disease 
can be cured  might have lead to such results but 
another important reason for dropping out are the 
side effects of the treatment itself. Most commonly 
seen adverse effects are  the  upper airway symptoms 
(46-73%) like nasal congestion, dry nose, mouth and 
throat and discomfort associated with cold air (22). 
strategies to improve adherence to CPAP that have 
been tested are broadly categorized as educational, 
technological, psychosocial, pharmacological, and 
multi-dimensional. Different types of interventions to 
increase adherence of CPAP mainly the addition of 
humidification has been studied, but the results 
remain contradictory. ın a prospective cross over 
study 44 patients with OsA were randomised  to 
either CPAP with controlled heated breathing tube or 
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CPAP without humidification for one night and  vice 
versa for the second night. Then the patients were 
randomised again for home treatment for a period of 
4 weeks (23). The results of the study showed no 
improvement on compliance or quality of life, but in 
the first 2 nights of treatment dryness of mouth 
decreased and the subjective sleep quality measured 
by questionnaires was in favor of humidification ther-
apy (23). On the other hand in controlled heated 
breathing tube usage as the condensation is prevent-
ed within tube it can cause wetness on face. 
similiarly in this study  the wake up due to wetness 
on face was increased, which means the adjustment 
of temperature and humidity level should be careful-
ly monitored (23). 
Massie et al. in a short term study randomised 
patients starting CPAP treatment into 2 groups: cold 
humidificiation or heated humidification for 3 weeks 
and then a washout period of 2 weeks which consist-
ed of no humidfication was applied (24).  Compliance, 
satisfaction of treatment and feeling refreshed on 
awaking were significantly higher in heated humidi-
fication group. side effects like dry nose, mouth and 
throat were less frequent with heated humidification 
when compared to CPAP without humidity (24). 
similiarly neill et al. compared heated humidifica-
tion versus placebo humidification in a short term (3 
weeks) randomised study and found that compliance 
increased slightly especially at the end of the first 
week with humidification and upper airway adverse 
effects decreased, but there was no difference in 
sleepiness or satisfaction degree of the patients (25).
On the other hand, Wiest et al. showed that the usage 
of prophylactic humidification in the initial titration 
of untreated OsAs patients did not improve the 
acceptance or increase the comfort of the treatment 
(26). similiarly duog et al. in a randomised parallel 
double blinded controlled study, showed no addi-
tional benefit of humidification in nasal symptoms at 
the initial titration thus not recommending its usage 
routinely (27). Taking in consideration the results of 
these short term studies it seems like the group of 
patients who might benefit more from the humidifi-
cation therapy are the ones who present or complain 
about upper airway symptoms while using CPAP. 
Rokatonanahary et al. in their study included only 
patients with nasal symptoms and showed that heat-
ed humidification did increase the compliance of 
CPAP treatment significantly in this group of patients. 
They also defined risk factors which might lead to 
upper airway symptoms like age over 60 years, usage 
of drugs that lead to dryness of mucosa,  presence of 
chronic nasal mucosal disease and prior surgery like 
uvulopalatopharyngoplasty (28). 
Another problem in patients with nasal symptoms is 
the increase in mouth leaks which further increases 
drying of nasal mucosa, the nasal resistance and 
nasal mucosal blood flux leading to a vicious cycle. 
Breathing and mouth leakage reduce humidity 80 to 
40% and the addition of heated humidification can 
increase the humidity level up to 60% and reduce 
the water loss during respiration by %38 (23,29). 
Wiest et al. in a study with 24 patients showed that 
the heated humidification reduces upper airway dry-
ness during CPAP (30). similiarly Arajuo et al. report-
ed a decrease in dehydration effect of inspired air 
when humidification was added to CPAP therapy 
(31). Cruz et al. showed that cold and dry air can 
lead to epithelial cell damage and speculated that 
this might be due to a mucosal water transportation 
defect which explains why the heated humidification 
leads to clinical improvement (32). 
As the CPAP treatment is usually recommended for 
continous and life-time usage it is important to know 
the long term effect of humidification on this treat-
ment. Mador and colleagues in a randomized con-
trolled trial compared heated humidification to the 
standard care (22). ninety eight patients with OsAs 
who did not recieve CPAP treatment previously were 
randomised and then evaluated at periods of 1, 3 and 
12 months. The patients included in control group 
who developed upper airway symptoms that could 
not be treated by simple measures were switched to 
the heated humidification group. At the end of the 
study the results were similiar to short term studies. 
symptoms like dry nose, mouth and throat were 
found to be less frequent in heated humidification 
group, but no difference in compliance, quality of 
life or subjective sleepiness was detected between 
groups (22). ın another study Worsnop and col-
leagues evaluated patients with OsAs randomised to 
humidification versus no humidification groups for a 
period of 12 weeks.  Heated humidification reduced 
nasal symptoms like dry nose, dry mouth and sneez-
ing, but did not improve the overall adherence (33). 
Kline and Carlson compared heated versus cold and 
no-humidification addition to CPAP therapy for a 
period of 3 months and there was found no differ-
ence in compliance rates between groups, but the 
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frequency of drop-outs were seen more in the group 
recieving CPAP without humidification. The patients 
recieving heated humidification were the ones that 
had fewer complaints of nasal symptoms (34). 
The delivery of humidity in CPAP treatment can be 
influenced by the cool room temperatures e.g. during 
winter season, as the decrease of the temperature of 
air can reduce the maximum level of moisture that 
the air can hold and also cause the accumulation of 
water in breathing tube and increase in pressure 
swings in the mask during respiration. nilius et al. in 
a randomized controlled crossover trial showed that 
the integrated humidifier in CPAP equipment reduced 
singificantly the  condensation amount and this lead 
to an increase in total sleep time, longer stage 3, 4 
and REM sleep and decrease in overall side effects 
even when the room temperature was adjusted 
below 20ºC (35). 
Another issue is how to convience the non-compliant 
patients to turn back to treatment. Ballard et al.  con-
ducted a study in 204 non-compliant OsAs patients. 
They found that only 24% of them became compliant 
after interventions like mask optimization, heated 
humidification, topical nasal therapy and especially 
education for a period of 2 weeks (21). Addition of 
heated humidification alone had no detectable effect 
upon outcome, but 82% of patients had already pre-
viously recieved humidification with their CPAP 
treatment which means additional humidification is 
of no benefit. Education and supportive counselling 
were the measures shown to be the most effective to 
make non-compliant patients turn back to their treat-
ment (21). similiarly Wiese et al.  in their study com-
pared OsAs patients’ compliance in respect of video 
education (36). A 15 minute video showing two 
OsAs patients talking about their disease and its 
treatment was viewed to one group of patients and 
then compliance of the patients were compared to 
the ones who were not shown the video. The patients 
who watched the video at their first clinic were more 
likely to use the treatment and improvement in the 
rate of return of patients to the follow up was detect-
ed (36). This does emphasize that education of 
patients is quite important for the treatment compli-
ance and video education might be a simple choice.
Obstructive sleep apnea is associated with upper 
airway and systemic inflammation as CRP and cyto-
kines level increase in these patients. The release of 
inflammatory mediators can cause the development 
of the upper airway symptoms. On the other hand 
Constantinidis et al. demonstrated a prolonged 
mucocialiary transport time, dessication of the epi-
thelial surface and an inflammatory cell infiltration of 
mucosa after 3-10 months of CPAP usage (37).  CPAP 
itself can disrupt the equlibrium of mucous mem-
brane and increase the inflammation of nasal mucosa 
(38). so not only the OsA disorder but also its treat-
ment can cause upper airway inflammation and it is 
crucial to take measures for minimizing or treating 
such conditions. 20 patients with OsA, who exhibit-
ed symptomatic nasal obstruction were randomised 
to recieve 3 weeks of CPAP with heated humidifica-
tion or with sham-heated therapy followed by 3 
weeks of the reverse treatment respectively. Measures 
of cytokines from the nasal lavage showed a decrease 
in pro-inflammatory cytokines: ıl-6,-12 and TnF-α in 
the heated humidification group. ın addition a 
decrease in nasal  symptomatology, resistance, atten-
uation of inflammatory cells infiltration and degree of 
fibrosis of the nasal mucosa was detected in the 
humidification group when compared to the control 
(38). 
What about the inflammatory process at the lower 
airway system? ıs it a part of the scenario as well? 
Devoussaus et al. detected bronchial neutrophilia at 
a level seen  in COPD patients especially smokers 
and a high ıl-8 level in untreated OsAs patients 
when compared to controls (39). Even after one 
month of CPAP treatment no change in inlammatory 
profile was detected. ın addition an increase in air-
way hyperresponsiveness without changes in pulmo-
nary function tests was noted (39). ın COPd patients 
the increase of inflammation could be explained by 
factors like smoking, but OsA patients involved in 
this study were all non-smokers. Possible mecha-
nisms involved in inflammation of airways in OsAs 
can be variable. Muscle hyperactivity commonly 
seen in this disorder is associated with local muscu-
lar proinflammatory cytokine production.  On the 
other hand desaturation-reoxygenation can lead to 
an increase in oxidative stress. Other comorbidities 
like gastro esophageal reflux disease, microaspira-
tions, obesity might lead to a pro-inflammatory state 
as well (39). Yet we still do not know the long term 
effect of CPAP and humidification on airway inflam-
mation and studies addressing this issue should be 
carefully planned. A treatment choice for upper air-
way inflammation might be corticosteroids. Topical 
nasal steroids are frequently prescribed as an alterna-
Tuberk Toraks 2018;66(1):57-63
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tive approach to treat nasal complaints associated 
with CPAP especially allergic rhinitis. Ryan and col-
leagues in their study randomised 125 patients with 
AHı score ≥ 10/h, who already used CPAP into 3 
groups: CPAP without humidification, with heated 
humidification and regular topical nasal steroids 
application in addition to CPAP therapy for a period 
of 4 weeks (40). They found no difference in compli-
ance between groups, but nasal symptoms were less 
frequent in humidification group. Topical nasal ste-
roid usage was found to be inferior when compared 
to heated humidification as far as concerns the inci-
dence of nasal side effects, thus concluding that 
nasal steroids should not be prescribed routinely to 
these patients (40).
The difference in results in various studies might be 
due to difficulty in study design, lack of reproducibil-
ity, a low number of patients involved, especially the 
control group, lack of blindness, difficulty to fol-
low-up patients and their outcomes or side effects 
and questionnaires which remain a subjective type of 
evaluation. The major clinical challenge is to improve 
the long term adherence to CPAP treatment. 
Eventhough in the majority of studies the addition of 
humidification did not show a significant improve-
ment for compliance it should be kept in mind that 
adherence might be also affected from other factors 
like relief of symptoms related to OsAs, mask com-
fort, disease severity rather than isolated nasal symp-
toms. ımprovement of side effects are quite important 
for the treatment adherence and more studies about 
the long-term effect of humidification are needed to 
elucidate the overall role it plays in treatment of not 
only OsAs patients but all the others who need non-
invasive mechanichal ventilation.
CONClUSıON
Based on the available data proper humidification 
systems may improve the outcomes of patients 
receiving nıV.  Multi-center studies with large num-
ber of patients are needed to identify patients’ groups 
who are likely to benefit from the addition of humid-
ification to nıV therapy and to assess the effect of 
humidification on adherence to nıV, and its effect on 
different outcome measures. 
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